The Research Advisory Council's members bring a diverse background of experience from private industry, research and the non-profit worlds to support Mass General's research enterprise.
Research Advisory Council Chairman
- Charles A. Sanders, MD
Mass General Hospital, Former General Director
Glaxo, Inc., Retired Chairman
Research Advisory Council Interim Chairman
- Samuel O. Thier, MD
Partners HealthCare System, Former President and Chief Executive Officer
Research Advisory Council Members
- James I. Cash, Jr., PhD
Professor and Senior Associate Dean, Emeritus, Harvard Business School - Brit J. d'Arbeloff
- Deborah Dunsire, MD
President and Chief Executive Officer, Millennium: The Takeda Oncology Company - Scott Eston
- Jean-Francoise Formela, MD
Partner, Atlas Venture - Jean de Gunzburg, PhD
Chief Scientific Officer, DaVolterra - Robert F. Higgins
General Partner, Highland Capital Partners - Janet James
General Partner and Chief Operating Officer, Rockport Capital - Rajiv Kaul
Portfolio Manager, Fidelity Investments - James F. Orr III
The Rockefeller Foundation - John T. Potts, Jr., MD
Massachusetts General Hospital
Director of Research, Emeritus
Physician-in-Chief, Emeritus - Phyllis E. Rappaport
Co-Founder, CURE Alzheimer's Fund - Michael Rosenblatt, MD
Chief Medical Officer, Merck & Co., Inc. - George A. Scangos, PhD
Chief Executive Officer, Biogen Idec - Robert I. Tepper, MD
Partner, Third Rock Ventures - Christoph Westphal, MD, PhD
Longwood Founders Fund
Verastem
Ex-Offico Members
- Daniel A. Haber, MD, PhD
ECOR Past Chair
Director, Massachusetts General Hospital Cancer Center
Isselbacher/Schwartz Professor of Oncology - Robert E. Kingston, PhD
ECOR Chair
Chief, Mass General Department of Molecular Biology - David N. Louis, MD
ECOR Vice Chair
Pathologist-in-Chief, Mass General - Harry W. Orf, PhD
Senior Vice President for Research, Mass General - Jack W. Szostak, PhD
Nobel Laureate in Medicine
Alex. A Rich Distinguished Investigator
Mass General Department of Molecular Biology
